Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA01050454 (R)-2-ethylmalic acid (2R)-2-ethyl-2-hydroxybutanedioic acid FA 6:1;O3 C6H10O5 162.052825
LMFA01050454 (R)-2-ethylmalic acid (2R)-2-ethyl-2-hydroxybutanedioic acid FA 6:1;O3 C6H10O5 162.052825
LMFA07070080 Malonylcarnitine (3S)-3-[(2-carboxyacetyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 3:1;O2 C10H17NO6 247.105589
LMFA07010868 Ethyl 4-decenoate ethyl (4E)-dec-4-enoate SFE 12:1 C12H22O2 198.161980
LMFA07010868 Ethyl 4-decenoate ethyl (4E)-dec-4-enoate SFE 12:1 C12H22O2 198.161980
LMFA07010876 Ethyl hydrogen fumarate (2Z)-4-ethoxy-4-oxobut-2-enoic acid SFE 6:2;O2 C6H8O4 144.042260
LMFA07010876 Ethyl hydrogen fumarate (2Z)-4-ethoxy-4-oxobut-2-enoic acid SFE 6:2;O2 C6H8O4 144.042260
LMFA07010988 Pentyl 3-methylbutanoate pentyl 3-methylbutanoate WE 10:0 C10H20O2 172.146330
LMFA07010988 Pentyl 3-methylbutanoate pentyl 3-methylbutanoate WE 10:0 C10H20O2 172.146330
LMFA07070016 (2E,5Z,7E)-decatrienoylcarnitine 3-[(2E,5Z,7E)-deca-2,5,7-trienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 10:3 C17H27NO4 309.194009
LMFA07070016 (2E,5Z,7E)-decatrienoylcarnitine 3-[(2E,5Z,7E)-deca-2,5,7-trienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 10:3 C17H27NO4 309.194009
LMFA07070033 2-Hydroxymyristoylcarnitine 3-[(2-hydroxytetradecanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 14:0;O C21H41NO5 387.298474
LMFA07070033 2-Hydroxymyristoylcarnitine 3-[(2-hydroxytetradecanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 14:0;O C21H41NO5 387.298474
LMFA07070042 3-hydroxylinoleoylcarnitine 3-{[(9Z,12Z)-3-hydroxyoctadeca-9,12-dienoyl]oxy}-4-(trimethylammonio)butanoate CAR 18:2;O C25H45NO5 439.329774
LMFA07070042 3-hydroxylinoleoylcarnitine 3-{[(9Z,12Z)-3-hydroxyoctadeca-9,12-dienoyl]oxy}-4-(trimethylammonio)butanoate CAR 18:2;O C25H45NO5 439.329774
LMFA07070042 3-hydroxylinoleoylcarnitine 3-{[(9Z,12Z)-3-hydroxyoctadeca-9,12-dienoyl]oxy}-4-(trimethylammonio)butanoate CAR 18:2;O C25H45NO5 439.329774
LMFA07011011 Rhodinyl butyrate 3,7-dimethyloct-7-en-1-yl butanoate SFE 14:1 C14H26O2 226.193280
LMFA07011011 Rhodinyl butyrate 3,7-dimethyloct-7-en-1-yl butanoate SFE 14:1 C14H26O2 226.193280
LMFA07011011 Rhodinyl butyrate 3,7-dimethyloct-7-en-1-yl butanoate SFE 14:1 C14H26O2 226.193280
LMFA07010965 methyl oleate methyl (9Z)-octadec-9-enoate SFE 19:1 C19H36O2 296.271531
LMFA07010965 methyl oleate methyl (9Z)-octadec-9-enoate SFE 19:1 C19H36O2 296.271531
LMFA07010954 Methyl 4-pentenoate methyl pent-4-enoate SFE 6:1 C6H10O2 114.068080
LMFA07010954 Methyl 4-pentenoate methyl pent-4-enoate SFE 6:1 C6H10O2 114.068080
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA07050399 Valproyl-CoA {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2-propylpentanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid CoA 8:0 C29H50N7O17P3S 893.219674
LMFA02030026 ent-9-B1-PhytoP (R,E)-11-(2-ethyl-5-oxocyclopent-1-en-1-yl)-9-hydroxyundec-10-enoic acid FA 18:4;O2 C18H28O4 308.198761
LMFA04020371 (10R,13R,16R)-d11-14-NeuroF[14S,17R] (4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-((2S,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA01140107 Alutacenoic acid A 6-(3-oxocyclopropen-1-yl)hexanoic acid FA 9:3;O C9H12O3 168.078645
LMFA01140107 Alutacenoic acid A 6-(3-oxocyclopropen-1-yl)hexanoic acid FA 9:3;O C9H12O3 168.078645
LMFA01140107 Alutacenoic acid A 6-(3-oxocyclopropen-1-yl)hexanoic acid FA 9:3;O C9H12O3 168.078645
LMFA01140108 Alutacenoic acid B 8-(3-oxocyclopropen-1-yl)octanoic acid FA 11:3;O C11H16O3 196.109945
LMFA01140108 Alutacenoic acid B 8-(3-oxocyclopropen-1-yl)octanoic acid FA 11:3;O C11H16O3 196.109945
LMFA01140108 Alutacenoic acid B 8-(3-oxocyclopropen-1-yl)octanoic acid FA 11:3;O C11H16O3 196.109945
LMFA04010170 7-D4t-NeuroP (S,4Z,8E)-7-hydroxy-9-((1S,2R,5S)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid FA 22:6;O3 C22H32O5 376.224976
LMFA02000296 Ixoric acid 8Z,10Z,12Z,14E-octadecatetraenoic acid FA 18:4 C18H28O2 276.208930
LMFA02000296 Ixoric acid 8Z,10Z,12Z,14E-octadecatetraenoic acid FA 18:4 C18H28O2 276.208930
LMFA01070023 13,14-epoxy-7Z,10Z-Hexadecenoic acid 13,14-epoxy-7Z,10Z-Hexadecenoic acid FA 16:3;O C16H26O3 266.188195
LMFA01070023 13,14-epoxy-7Z,10Z-Hexadecenoic acid 13,14-epoxy-7Z,10Z-Hexadecenoic acid FA 16:3;O C16H26O3 266.188195
LMFA01050541 8-Hydroxypalmitic acid 8-Hydroxyhexadecanoic acid FA 16:0;O C16H32O3 272.235146
LMFA08010031 11-hydroxy-11-methyldodecanamide NA 13:0;O C13H27NO2 229.204179
LMFA02000310 12-Keto-9Z,13Z,15Z-octadecatrienoic acid 12-Oxo-9Z,13Z,15Z-octadecatrienoic acid FA 18:4;O C18H28O3 292.203846
LMFA02000310 12-Keto-9Z,13Z,15Z-octadecatrienoic acid 12-Oxo-9Z,13Z,15Z-octadecatrienoic acid FA 18:4;O C18H28O3 292.203846
LMFA02000310 12-Keto-9Z,13Z,15Z-octadecatrienoic acid 12-Oxo-9Z,13Z,15Z-octadecatrienoic acid FA 18:4;O C18H28O3 292.203846
LMFA01050551 5-Acetoxy-tetradeca-2E,4E,6E-trienoic acid 5-Acetoxy-2E,4E,6E-tetradecatrienoic acid FA 16:4;O2 C16H24O4 280.167460
LMFA01050551 5-Acetoxy-tetradeca-2E,4E,6E-trienoic acid 5-Acetoxy-2E,4E,6E-tetradecatrienoic acid FA 16:4;O2 C16H24O4 280.167460
LMFA04020049 (13R,16R,20R)-d18-14-NeuroF[14R,17R] (R,4Z,7Z,10Z)-13-hydroxy-13-((2R,4R,5R)-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,10-trienoic acid FA 22:5;O4 C22H34O6 394.235541